GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

Similar to trimming, an electric buzzer is a safe and easy way to remove nasal hair. This quick and painless method will save ...

These polyps can cause various symptoms, including nasal obstruction, discharge, and headaches. Endoscopic sinus surgery is a common treatment for these polyps, allowing for direct visualization ...

Nose and nasal injuries can range from minor ones that can be treated at home to more serious issues that require ...

(Alliance News) - GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal polyps, or CRSwNP, have been accepted for review in China, Japan and ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

"The sniffles" is a slang term that usually refers to nasal congestion (stuffy nose ... Though you can't cure your illness, there are some ways to help you feel better while you're sick, including ...